TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15613167

Group type: EXPERIMENTAL
Intervention: Butorphanol nasal spray 1 mg followed by optional second 1 mg dose
Number of subjects: 321

Group type: COMPARATOR
Intervention: Fiorinal with Codeine (one capsule containing butalbital 50 mg, caffeine 40 mg, aspirin 325 mg, and codeine phosphate 30 mg)
Number of subjects: 321
Study: 7609510

Group type: EXPERIMENTAL
Intervention: Lacidipine
Number of subjects: 4800

Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 4800
Study: 3303427

Group type: EXPERIMENTAL
Intervention: Aerosol A (Turret nebuliser, MMD 1.8 micron)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aerosol B (Upmist nebuliser, MMD 4.6 microns)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aerosol C (Inspiron Mini-neb, MMD 10.3 microns)
Number of subjects: 6
Study: 28535964

Group type: EXPERIMENTAL
Intervention: Low income
Number of subjects: 381

Group type: COMPARATOR
Intervention: Low educational level
Number of subjects: 381

Group type: COMPARATOR
Intervention: High perceived stress
Number of subjects: 381
Study: 27008577

Group type: EXPERIMENTAL
Intervention: Topical ropivacaine (injected at three portal sites and atomized in the abdominal cavity)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Topical ropivacaine
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 24760248

Group type: EXPERIMENTAL
Intervention: Magnesium oxide (500 mg twice a day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 23304972

Group type: EXPERIMENTAL
Intervention: RME activation protocols
Number of subjects: 60
Study: 20479546

Group type: EXPERIMENTAL
Intervention: GPD (gemcitabine, dexamethasone, cisplatine)
Number of subjects: 96

Group type: COMPARATOR
Intervention: ESHAP (etoposide, cisplatine, solumedrol, aracytine)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: GPD
Number of subjects: 96

Group type: COMPARATOR
Intervention: ESHAP
Number of subjects: 96
Study: 18714603

Group type: EXPERIMENTAL
Intervention: Person-centered caregiving training (2-hour program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (students who did not complete the training)
Number of subjects: 0
Study: 15683891

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Polymyxin B
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combination neomycin‐polymyxin B‐hydrocortisone
Number of subjects: 75

Group type: COMPARATOR
Intervention: Positive control (no intracanal medicament)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Negative control (no endotoxin and no intracanal medicament)
Number of subjects: 75
Study: 12598751

Group type: EXPERIMENTAL
Intervention: Laparoscopic RFA
Number of subjects: 23

Group type: COMPARATOR
Intervention: RFA via laparotomy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Percutaneous RFA
Number of subjects: 23
Study: 10589274

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg daily
Number of subjects: 1663

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1663

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1663
Study: 8614496

Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment
Number of subjects: 83
Study: 2018818

Group type: EXPERIMENTAL
Intervention: Cerebral electrostimulation (electrosleep)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 7328569

Group type: EXPERIMENTAL
Intervention: 150 mg of levamisole on 3 consecutive days
Number of subjects: 100

Group type: COMPARATOR
Intervention: 150 mg of levamisole once weekly
Number of subjects: 100
Study: 31927219

Group type: EXPERIMENTAL
Intervention: Typical strategies PFI
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Strategy norms PFI
Number of subjects: 268

Group type: COMPARATOR
Intervention: Assessment-only control (AOC)
Number of subjects: 268
Study: 29943890

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 6214
Study: 26620373

Group type: EXPERIMENTAL
Intervention: Canola oil rich in docosahexanoic acid (DHA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional canola oil (Canola)
Number of subjects: 54

Group type: COMPARATOR
Intervention: High-oleic acid canola oil (CanolaOleic)
Number of subjects: 54
Study: 24768155

Group type: EXPERIMENTAL
Intervention: Pulse oximetry plus clinical assessment
Number of subjects: 122738

Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 122738

Group type: COMPARATOR
Intervention: Pulse oximetry alone
Number of subjects: 122738
Study: 22301338

Group type: EXPERIMENTAL
Intervention: PU stent
Number of subjects: 50

Group type: COMPARATOR
Intervention: PE stent
Number of subjects: 50
Study: 20053398

Group type: EXPERIMENTAL
Intervention: 200mg of oral mifepristone followed by 400 microg of oral misoprostol (group 1)
Number of subjects: 252

Group type: COMPARATOR
Intervention: 800 microg of sublingual misoprostol repeated every 4 hours for up to a maximum of 3 doses (group 2)
Number of subjects: 252
Study: 18853552

Group type: EXPERIMENTAL
Intervention: Stimulus diameter of 62 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus diameter of 30 degrees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stimulus diameter of 5 degrees
Number of subjects: 0

Group type: COMPARATOR
Intervention: Same-eye adapt/test durations
Number of subjects: 0
Study: 16468528

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg preoperatively
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 15211533

Group type: EXPERIMENTAL
Intervention: Light therapy (5000 lux for 50 minutes per day for 5 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0
Study: 10858728

Group type: EXPERIMENTAL
Intervention: NIDDM patients with diabetes duration of 1-2.5 years
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NIDDM patients with diabetes duration of 4 years
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NIDDM patients with diabetes duration of 5-27 years (Group 2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NIDDM patients with chronic neurogenic symptoms
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: NIDDM patients with carpal tunnel syndrome
Number of subjects: 32
Study: 9386203

Group type: EXPERIMENTAL
Intervention: Exercise at 100% maximum power output
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise at 70% maximum power output
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 0
Study: 1493624

Group type: EXPERIMENTAL
Intervention: Cisplatinum + nifedipine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cisplatinum
Number of subjects: 40
Study: 4034296

Group type: EXPERIMENTAL
Intervention: Subcutaneous growth hormone therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular growth hormone therapy
Number of subjects: 20
Study: 31870046

Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (MIPO) through anterior approach (group A)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Minimally invasive plate osteosynthesis (MIPO) through lateral approach (group B)
Number of subjects: 76
Study: 29996928

Group type: EXPERIMENTAL
Intervention: Global engagement strategy involving all health professionals from the beginning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential engagement strategy starting with nurses then involving doctors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 0
Study: 27094945

Group type: EXPERIMENTAL
Intervention: PF-06743649 (40 mg dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-06743649
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25143717

Group type: EXPERIMENTAL
Intervention: Traditional Thai massage (TTM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional physical therapy (PT)
Number of subjects: 50
Study: 22891748

Group type: EXPERIMENTAL
Intervention: Azithromycin (30 mg/kg once a week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (once a week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study: 19748247

Group type: EXPERIMENTAL
Intervention: Tall oil sterol margarine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Rapeseed sterol margarine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control margarine
Number of subjects: 59
Study: 18723857

Group type: EXPERIMENTAL
Intervention: Morphine (100 microg kg(‐1) loading dose; 10-30 microg kg(‐1) h(‐1) infusion for 14 days)
Number of subjects: 898

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 898
Study: 15759252

Group type: EXPERIMENTAL
Intervention: Spinergy wheels
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard steel-spoke wheels
Number of subjects: 20
Study: 12658028

Group type: EXPERIMENTAL
Intervention: Guanabenz (2 mg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Guanabenz (4 mg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Clonidine (75 microg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Clonidine (150 microg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 133
Study: 9804037

Group type: EXPERIMENTAL
Intervention: Antisocial families (ADHD with comorbidity)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-antisocial families
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control families
Number of subjects: 0
Study: 7641351

Group type: EXPERIMENTAL
Intervention: Directional Coronary Atherectomy (DCA)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Percutaneous Transluminal Coronary Angioplasty (PTCA)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: DCA
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Presence of thrombus
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Distal embolization
Number of subjects: 305
Study: 2540785

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 17

Group type: COMPARATOR
Intervention: No drug treatment (Control)
Number of subjects: 17
Study: 339337

Group type: EXPERIMENTAL
Intervention: Isobutane exposure at concentrations of 500 ppm for 1, 2, or 8 hours per day, five days per week for two weeks.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isobutane and propane mixtures for 1, 2, or 8 hours per day for two days.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Continuous ECG telemetry and serial computerized spirometric measurements.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Serial laboratory studies including complete blood count, urinalysis, serum alkaline phosphatase, SGOT, LDH, serum bilirubin, blood sugar, serum calcium, serum phosphorus, BUN, spontaneous electroencephalogram, visual evoked response, cognitive tests, ACTH stimulation test.
Number of subjects: 8
Study: 31236689

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Minimally invasive thoracoscopic PVI and left atrial appendage ligation (MIPI)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both CA and MIPI
Number of subjects: 52
Study: 29032449

Group type: EXPERIMENTAL
Intervention: Self-Help Cognitive Behavioral Treatment (SHCBT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 55
Study: 27119581

Group type: EXPERIMENTAL
Intervention: Softgel capsule (diclofenac potassium 50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral solution (diclofenac potassium 50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tablet (diclofenac potassium 50 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Softgel capsule vs Oral solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Softgel capsule vs Tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Softgel capsule
Number of subjects: 0
Study: 24884854

Group type: EXPERIMENTAL
Intervention: TBL + LBL (Group A, 41 students)
Number of subjects: 127

Group type: COMPARATOR
Intervention: LBL (Group B, 43 students)
Number of subjects: 127

Group type: COMPARATOR
Intervention: TBL (Group C, 43 students)
Number of subjects: 127
Study: 22367274

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy by a trained nurse for 10 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Telephone calls only for 10 weeks
Number of subjects: 27
Study: 20139154

Group type: EXPERIMENTAL
Intervention: i.p. chemotherapy
Number of subjects: 89
Study: 18368792

Group type: EXPERIMENTAL
Intervention: Gastric metaplasia in the duodenum
Number of subjects: 124
Study: 15839930

Group type: EXPERIMENTAL
Intervention: Ureteroscopy plus intracorporeal lithotripsy (ULT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: ESWL (second treatment)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ULT
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ULT and ESWL
Number of subjects: 31
Study: 12401756

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 24
Study: 10430693

Group type: EXPERIMENTAL
Intervention: Rigid videosigmoidoscope
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional sigmoidoscope
Number of subjects: 58
Study: 7749710

Group type: EXPERIMENTAL
Intervention: Laparoscopic tension-free mesh repair
Number of subjects: 242

Group type: COMPARATOR
Intervention: Lichtenstein tension-free mesh repair
Number of subjects: 242
Study: 2193278

Group type: EXPERIMENTAL
Intervention: Xylocaine (lidocaine) aerosol 10%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lidocaine 4%
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lidocaine hydrochloride 5%
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6865429

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low alcohol doses
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High alcohol doses
Number of subjects: 40
Study: 30819926

Group type: EXPERIMENTAL
Intervention: Carfilzomib-melphalan-prednisone (KMP)
Number of subjects: 955

Group type: COMPARATOR
Intervention: Bortezomib-melphalan-prednisone (VMP)
Number of subjects: 955
Study: 29800093

Group type: EXPERIMENTAL
Intervention: Mitral Valve Repair
Number of subjects: 1122

Group type: COMPARATOR
Intervention: Mitral Valve Replacement
Number of subjects: 1122
Study: 27380104

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus-intercostal plane block and intermediate cervical plexus blocks (block group, n = 11)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No block (control group, n = 11)
Number of subjects: 22
Study: 24147809

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 67
Study: 22865490

Group type: EXPERIMENTAL
Intervention: 600 mg tramadol and 100 mg dexketoprofen trometamol
Number of subjects: 40

Group type: COMPARATOR
Intervention: 600 mg tramadol with 100 ml 0.9% normal saline
Number of subjects: 40
Study: 19937984

Group type: EXPERIMENTAL
Intervention: Spinal saddle block (1.0 ml 0.5 per cent hyperbaric bupivacaine)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA) with propofol and fentanyl
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Spinal saddle block
Number of subjects: 201

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia (TIVA)
Number of subjects: 201
Study: 17991935

Group type: EXPERIMENTAL
Intervention: Care by general practitioners specially trained in management of hypertension
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 15800328

Group type: EXPERIMENTAL
Intervention: Parenteral hydration with 1,000 mL administered over 4 hours for 2 days
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo with 100 mL normal saline administered over 4 hours for 2 days
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Parenteral hydration
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 11921156

Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg per day for the first four weeks, then 10 mg per day thereafter)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9617020

Group type: EXPERIMENTAL
Intervention: Itraconazole and secnidazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fluocinolone, nystatin, and metronidazole (vaginal ovules)
Number of subjects: 40
Study: 8580047

Group type: EXPERIMENTAL
Intervention: Word processing intervention
Number of subjects: 14
Study: 2572628

Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 0
Study: 334478

Group type: EXPERIMENTAL
Intervention: 150 mg flurbiprofen daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: 75 mg indomethacin daily
Number of subjects: 30
Study: 26142337

Group type: EXPERIMENTAL
Intervention: FRG + GP chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: GP chemotherapy alone
Number of subjects: 60
Study: 25534295

Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin (CD)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (CP)
Number of subjects: 259
Study: 23876971

Group type: EXPERIMENTAL
Intervention: Indometacin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 21399960

Group type: EXPERIMENTAL
Intervention: Isotonic (IT) eccentric contractions
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isokinetic (IK) eccentric contractions
Number of subjects: 17

Group type: COMPARATOR
Intervention: Both IT and IK modes
Number of subjects: 17
Study: 19760931

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Doppler guided haemorrhoidal artery ligation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional haemorrhoidectomy
Number of subjects: 45
Study: 17383302

Group type: EXPERIMENTAL
Intervention: Comprehensive cardiac rehabilitation (CCR)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 104
Study: 15365928

Group type: EXPERIMENTAL
Intervention: Thoracic epidural block with 7 mL of lidocaine 2% and repeated doses of 5 mL of lidocaine 2% during the operation.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Indomethacin suppository (NSAID)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 32
Study: 11136300

Group type: EXPERIMENTAL
Intervention: Oral verapamil 80 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 16
Study: 8781009

Group type: EXPERIMENTAL
Intervention: DARE intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 31
Study: 1333267

Group type: EXPERIMENTAL
Intervention: Intravenous 6-thioguanine (6-TG) at 55 mg/m2 administered over 30 minutes for 5 consecutive days, repeated every 35 days.
Number of subjects: 95

Group type: COMPARATOR
Intervention: Cisplatin (100 mg/m2 on day 1), 5-fluorouracil (800 mg/m2/day as continuous intravenous infusion over 5 days), and oral leucovorin (100 mg every 4 hours during the entire duration of cisplatin and 5-FU infusions), repeated every three weeks.
Number of subjects: 95
Study: 3881497

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lorcainide
Number of subjects: 30
Study: 31340012

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1200 IU/d)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 30420289

Group type: EXPERIMENTAL
Intervention: LCB01-0371 400-1600 mg BID for 7 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LCB01-0371 800 mg single oral dose
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LCB01-0371 400 mg tablet
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LCB01-0371
Number of subjects: 32
Study: 27351713

Group type: EXPERIMENTAL
Intervention: Abdominal drainage
Number of subjects: 414

Group type: COMPARATOR
Intervention: No abdominal drainage
Number of subjects: 414
Study: 25758845

Group type: EXPERIMENTAL
Intervention: Tooth brushing
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Single tooth extraction
Number of subjects: 98

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis (AP)
Number of subjects: 98
Study: 23040973

Group type: EXPERIMENTAL
Intervention: Long-term growth hormone (GH) therapy
Number of subjects: 851

Group type: COMPARATOR
Intervention: General population (control)
Number of subjects: 851
Study: 20671099

Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Sling exercises
Number of subjects: 109

Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 109
Study: 17954694

Group type: EXPERIMENTAL
Intervention: Intravenous tigecycline (100 mg loading dose followed by 50 mg every 12 h or 50 mg loading dose followed by 25 mg every 12 h)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cohort 4 (21 patients, 50 pathogens)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cohort 5 (31 patients, 60 pathogens)
Number of subjects: 71
Study: 16632821

Group type: EXPERIMENTAL
Intervention: TIVA (propofol/remifentanil)
Number of subjects: 22

Group type: COMPARATOR
Intervention: SEVO (sevoflurane/remifentanil)
Number of subjects: 22
Study: 12594143

Group type: EXPERIMENTAL
Intervention: Propacetamol
Number of subjects: 550

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study: 10810425

Group type: EXPERIMENTAL
Intervention: Anti-H. pylori treatment
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 8792790

Group type: EXPERIMENTAL
Intervention: Quality assurance interventions
Number of subjects: 630
Study: 1473452

Group type: EXPERIMENTAL
Intervention: Oral acyclovir
Number of subjects: 22

Group type: COMPARATOR
Intervention: No acyclovir (Control)
Number of subjects: 22
Study: 6365803

Group type: EXPERIMENTAL
Intervention: Penbutolol (40 mg daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26